Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11759527 Anti-EGFR antibody-drug conjugates

Patent 11759527 was granted and assigned to AbbVie Inc. on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 20 Sep, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 20 Sep, 2023
Edits made to:
Infobox (+72 properties)
Article (+233 characters)
‌

 US Patent 11759527 Anti-EGFR antibody-drug conjugates

Article

Patent abstract

The present disclosure relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods using such ADCs, and methods for making such ADCs.

Infobox
Is a
Patent
Patent
Patent Applicant
AbbVie Inc.
AbbVie Inc.
Current Assignee
AbbVie Inc.
AbbVie Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11759527
Patent Inventor Names
Andrew C. Phillips
Andrew J. Souers
Erwin R. Boghaert
John E. Harlan
Kamel Izeradjene
Date of Patent
September 19, 2023
Patent Application Number
17580134
Date Filed
January 20, 2022
Patent Citations
‌
US Patent 7223837 Elongated and multiple spacers in activatible prodrugs
‌
US Patent 7227002 Human antibodies that bind human 17-A1/EpCAM tumor antigen
‌
US Patent 7263946 System for measuring chain or rope deployment
‌
US Patent 7422899 Antibodies to the human prolactin receptor
‌
US Patent 7447597 Data processing/visualization method for two (multi) dimensional separation gas chromatography xmass spectrometry (GCxMS) technique with a two (multiply) dimensional separation concept as an example
‌
US Patent 7507716 Method for treating pain with prolactin antagonists
‌
US Patent 7521541 Cysteine engineered antibodies and conjugates
‌
US Patent 7589180 Specific binding proteins and uses thereof
‌
US Patent 7598028 Compositions and methods for detecting and treating prostate disorders
‌
US Patent 7612181 Dual variable domain immunoglobulin and uses thereof
‌
US Patent 7723270 Methods for producing members of specific binding pairs
‌
US Patent 7741319 11-hydroxy-5h-pyrrolo[2,1-c][1,4] benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
‌
US Patent 7767792 Antibodies to EGF receptor epitope peptides
‌
US Patent 7855275 Cysteine engineered antibodies and conjugates
‌
US Patent 7867493 PRLR-specific antibody and uses thereof
‌
US Patent 7989434 Heterocyclic self-immolative linkers and conjugates
‌
US Patent 7994135 Monomethylvaline compounds capable of conjugation to ligands
‌
US Patent 8039273 β-glucuronide-linker drug conjugates
‌
US Patent 8142784 Antibody-drug conjugates and methods
‌
US Patent 8187836 Mammalian expression vectors and uses thereof
‌
US Patent 8236319 Cross-linkers and their uses
‌
US Patent 8301397 Method of determining physico-chemical properties of a petroleum sample from two-dimensional gas chromatography
‌
US Patent 8309093 Antibody drug conjugates (ADC) that bind to 24P4C12 proteins
‌
US Patent 8349308 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
‌
US Patent 8389282 Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
‌
US Patent 8399512 Biocompatible biodegradable fumagillin analog conjugates
‌
US Patent 8455219 Mammalian expression vectors and uses thereof
‌
US Patent 8455622 Variant target binding agents and uses thereof
‌
US Patent 8524214 Polyal drug conjugates comprising variable rate-releasing linkers
‌
US Patent 8535678 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
‌
US Patent 8568728 Beta-glucuronide-linker drug conjugates
‌
US Patent 8648046 Compositions and methods for visualizing and eliminating cancer stem cells
‌
US Patent 8754035 Compositions and methods for visualizing and eliminating cancer stem cells
‌
US Patent 8809051 Transgenic mammals having human Ig loci including plural V
‌
US Patent 8809151 Transistor comprising an embedded sigma shaped sequentially formed semiconductor alloy
‌
US Patent 8822647 Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells
‌
US Patent 8883979 Anti-prolactin receptor antibody formulations
‌
US Patent 8906682 Methods for treatment of cancer
‌
US Patent 8911993 Compositions for treatment of cancer
‌
US Patent 8916381 Methods for treatment of cancer
‌
US Patent 8975071 Compositions for treatment of cancer
‌
US Patent 9072798 Specific binding proteins and uses thereof
‌
US Patent 9105939 Battery with battery electrode and method of manufacturing same
‌
US Patent 9109630 Rolling bearing unit
‌
US Patent 9401234 Over-current protection device
‌
US Patent 9428082 System, methodologies, and components acquiring, analyzing, and using occupant body specifications for improved seating structures and environment configuration
‌
US Patent 9493568 Anti-EGFR antibodies and antibody drug conjugates
‌
US Patent 9562102 Specific binding proteins and uses thereof
‌
US Patent 9618978 Methods for controlling a touch panel and portable computers using the same
‌
US Patent 9649374 Neutralizing prolactin receptor antibodies and their therapeutic use
‌
US Patent 9827330 Anti-EGFR antibodies and antibody drug conjugates
‌
US Patent 10098968 Anti-EGFR antibodies and antibody drug conjugates
‌
US Patent 10112999 Anti-PRLR antibody-drug conjugates (ADC) and uses thereof
‌
US Patent 10184003 Prolactin receptor binding proteins and uses thereof
‌
US Patent 10640563 Anti-B7-H3 antibodies and antibody drug conjugates
Patent Primary Examiner
‌
Vanessa L. Ford
CPC Code
‌
A61K 47/6849
‌
A61K 47/6803
‌
A61K 2039/505

Find more entities like US Patent 11759527 Anti-EGFR antibody-drug conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo